NVOS (Novo Integrated Sciences) LT-Debt-to-Total-Asset : 0.05 (As of May. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Novo Integrated Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Novo Integrated Sciences's long-term debt to total assests ratio for the quarter that ended in May. 2024 was 0.05.

Novo Integrated Sciences's long-term debt to total assets ratio declined from May. 2023 (0.05) to May. 2024 (0.05). It may suggest that Novo Integrated Sciences is progressively becoming less dependent on debt to grow their business.

Novo Integrated Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Novo Integrated Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Integrated Sciences LT-Debt-to-Total-Asset Chart

Novo Integrated Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.12

0.09

0.13

0.08

0.05

Novo Integrated Sciences Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.05	0.04	0.05	0.05

Novo Integrated Sciences LT-Debt-to-Total-Asset Calculation

Novo Integrated Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

LT Debt to Total Assets (A: Aug. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2023 )	/	Total Assets (A: Aug. 2023 )
	=	1.759	/	35.563
	=	0.05

Novo Integrated Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in May. 2024 is calculated as

LT Debt to Total Assets (Q: May. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: May. 2024 )	/	Total Assets (Q: May. 2024 )
	=	1.598	/	35.327
	=	0.05

Novo Integrated Sciences (OTCPK:NVOS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Novo Integrated Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Novo Integrated Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Integrated Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novo Integrated Sciences Inc (OTCPK:NVOS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004

Website

https://www.novointegrated.com

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.

Executives

Sarfaraz Ali	director	C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Robert Letterio Oliva	director	115 BELFIELD RD, TORONTO A6 L0J 1C0
Sterling M. Jimenez	officer: Principal Financial Officer	C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Michael Ross Pope	director	1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043
Alex Flesias	director	41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7
Michael Joseph Gaynor	director	49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0
Robert Mattacchione	director, 10 percent owner, officer: Chief Executive Officer	79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1
Pierre Joseph Dalcourt	director, 10 percent owner	35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0
Christopher Mehlin David	director, officer: President	10425 SE 22ND ST., BELLEVUE WA 98004
Thomas Edward Bray	officer: Principal Financial Officer	C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Rebecca Aw Mcdonald	officer: Chief Accounting Officer	1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724
James Jr Teters	director	1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724
Phyllis Rouse	officer: secretary	1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Jay Hilden	officer: President & CEO	1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Robert Adamo	director	1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724